Marty St. George
PresidentJetBlue Airways
Go-to-MarketView Profile →President, Amerita and Infusion Pharmacy · BrightSpring Health Services
Rich Denness is President of Amerita and Infusion Pharmacy at BrightSpring Health Services. His background spans pharmaceutical leadership, management consulting and commercial roles in infusion services.
Last reviewed: Oct 30, 2026
President, Amerita and Infusion Pharmacy
BrightSpring Health Services
Last Reviewed: October 30, 2026
Rich Denness is President of Amerita and Infusion Pharmacy at BrightSpring Health Services. His background spans pharmaceutical leadership, management consulting and commercial roles in infusion services.
Denness held pharmaceutical leadership positions including general manager for Australia and New Zealand at Schering-Plough, president of IVAX Laboratories, vice president and general manager of neurology at UCB, and chief executive officer of Vycor Medical.
He subsequently worked in consulting, leading Proudfoot’s western United States business from July 2013 to September 2017 and serving as North Highland’s managing director and global healthcare lead from September 2017 to July 2018.
He joined BioScrip as senior vice president and chief commercial officer in July 2018. After its merger with Option Care, he became chief strategy officer in August 2019 and chief commercial officer in June 2020.
Denness later took leadership of Amerita, BrightSpring’s infusion services business. In March 2026, he presented its infusion pharmacy segment to investors and represented Amerita in its announcement of immunoglobulin therapy accreditation.
Denness earned a Bachelor of Science in marketing and finance from Missouri State University.